Видео ютуба по тегу Pcsk9-Targeting Therapies

Leveraging PCSK9-Targeting Therapies in Hyperlipidemia Management to Reduce Cardiovascular Risks
Leveraging PCSK9-Targeting Therapies in Hyperlipidemia Management to Reduce Cardiovascular Risks
Diagnosing and Treating Hyperlipidemia: Recent Evidence and the Role of PCSK9-targeted Therapies
Diagnosing and Treating Hyperlipidemia: Recent Evidence and the Role of PCSK9-targeted Therapies
PCSK9-Targeting Strategies to Achieve Lipid Goals & Reduce CV Risks in Hyperlipidemia
PCSK9-Targeting Strategies to Achieve Lipid Goals & Reduce CV Risks in Hyperlipidemia
PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16
PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16
Straight From the Experts: Modernizing Hyperlipidemia Management With PCSK9-Targeting Agents
Straight From the Experts: Modernizing Hyperlipidemia Management With PCSK9-Targeting Agents
Weighing the cost versus benefit of PCSK9-targeted therapy | Professor Lluis Masana
Weighing the cost versus benefit of PCSK9-targeted therapy | Professor Lluis Masana
Lipid Management Beyond Statins: Timely Intensification With PCSK9-Targeted Therapies
Lipid Management Beyond Statins: Timely Intensification With PCSK9-Targeted Therapies
Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C in Hyperlipidemia and ASCVD
Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C in Hyperlipidemia and ASCVD
Pushing the Envelope with PCSK9-Twenty Years of Progress
Pushing the Envelope with PCSK9-Twenty Years of Progress
PCSK9 Inhibition: Lowering Lipids and Reducing Cardiovascular Events
PCSK9 Inhibition: Lowering Lipids and Reducing Cardiovascular Events
What are the gaps in knowledge about the PCSK9 inhibitors | Dr Evan Stein
What are the gaps in knowledge about the PCSK9 inhibitors | Dr Evan Stein
Clinical Experience With PCSK9 Inhibitors
Clinical Experience With PCSK9 Inhibitors
A Real World Approach to LDL cholesterol using PCSK9 inhibitors, October 5 2018
A Real World Approach to LDL cholesterol using PCSK9 inhibitors, October 5 2018
Intertwined Roles of PCSK9 in Lipoprotein Metabolism and Inflammation - Weekly Research Conference
Intertwined Roles of PCSK9 in Lipoprotein Metabolism and Inflammation - Weekly Research Conference
Optimizing LDL-C Lowering With PCSK9 Inhibition
Optimizing LDL-C Lowering With PCSK9 Inhibition
Lipids Series-PCS K9 Inhibitors
Lipids Series-PCS K9 Inhibitors
PCSK9 inhibitors cost-effective since price reductions
PCSK9 inhibitors cost-effective since price reductions
What is PCSK9 inhibitor?
What is PCSK9 inhibitor?
The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia
The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia
Residual cardiovascular risk a role for PCSK9 inhibition | Professor Kausik Ray
Residual cardiovascular risk a role for PCSK9 inhibition | Professor Kausik Ray